| Hepatocyte Transplantation for Acute Decompensated Liver Failure (NCT01345565) | Ira Fox | 2011-03-01 |
| Efficacy of Azadirachta Indica (Homoeopathic Medicine) in Treatment of Acne Vulgaris (NCT01321645) | Miglani, Anjali | 2011-03-01 |
| A Trial to Evaluate the Safety and Tolerability of Namilumab (MT203) in Patients With Mild to Moderate Rheumatoid Arthritis (NCT01317797) | Takeda | 2011-03-01 |
| Electrocardiographic (ECG) Safety Study of Droxidopa at Clinical and Supratherapeutic Dose (NCT01327066) | Chelsea Therapeutics | 2011-03-01 |
| Reverse Genetic H9N2 Influenza Vaccine Study in Adults (NCT01320696) | Alachua Government Services, Inc. | 2011-03-01 |
| Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients (NCT01663116) | Tigenix S.A.U. | 2011-03-01 |
| Vitamin D for Treatment of Glioblastoma Multiforme (NCT01181193) | Soroka University Medical Center | 2011-03-01 |
| A Clinical Trial Assessing Safety of MF101 for Hot Flushes (NCT01300078) | Bionovo | 2011-03-01 |
| Study of the Combination of Axitinib Plus Everolimus in Patients With Malignant Advanced Solid Tumors (NCT01334073) | University Hospital, Bordeaux | 2011-03-01 |
| Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults (NCT01266616) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-03-01 |
| Green Tea Lozenges for the Management of Dry Mouth (NCT01647737) | Augusta University | 2011-03-01 |
| Pharmacokinetics of the Fixed Dose Combination of Tiotropium Plus BI 54903 Versus the Combination of the Monoproducts of Tiotropium and BI 54903 in Healthy Volunteers (NCT01309139) | Boehringer Ingelheim | 2011-03-01 |
| A Single Dose Study Of Antimineralocorticoid Activity Of PF-03882845 In Healthy Volunteers (NCT01314898) | Pfizer | 2011-03-01 |
| POETIC Plerixafor as a Chemosensitizing Agent for Relapsed Acute Leukemia and MDS in Pediatric Patients (NCT01319864) | Seattle Children's Hospital | 2011-03-01 |
| A Study to Assess the Effect of Ustekinumab (Stelara®) and Etanercept (Enbrel®) in Participants With Moderate to Severe Psoriasis (MK-0000-206) (NCT01276847) | Merck Sharp & Dohme LLC | 2011-03-01 |
| Safety Study of Inactivated Shigella Whole Cell Vaccine in Adults (NCT01509846) | PATH | 2011-03-01 |
| Safety Study of Flavocoxid in Duchenne Muscular Dystrophy (NCT01335295) | University of Messina | 2011-03-01 |
| Overcoming Membrane Transporters to Improve CNS Drug Delivery - Improving Brain Antioxidants After Traumatic Brain Injury (NCT01322009) | University of Pittsburgh | 2011-03-01 |
| Transcranial Magnetic Stimulation for Tinnitus (NCT01104207) | VA Office of Research and Development | 2011-03-01 |
| PD0332991/Paclitaxel in Advanced Breast Cancer (NCT01320592) | Abramson Cancer Center at Penn Medicine | 2011-03-01 |
| Phase I/II Study of ASP9521 in Castrate-Resistant Prostate Cancer (CRPC) Patients (NCT01352208) | Astellas Pharma Inc | 2011-03-01 |
| A Phase I Study of Lapatinib (Tykerb) Plus Ixabepilone (Ixempra) as 2nd-line Treatment for Patients With HER-2 Overexpressed Recurrent or Persistent Endometrial Carcinoma or Carcinosarcoma (NCT01454479) | Hung-Hsueh Chou | 2011-03-01 |
| Single and Multiple Ascending Dose Study for NKTR-118 and Cross-over Study to Investigate the Effect of Food for NKTR-118 in Japanese Healthy Subjects (NCT01318655) | AstraZeneca | 2011-03-01 |
| Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Empagliflozin in Chinese Female and Male Patients With Type 2 Diabetes Mellitus (NCT01316341) | Boehringer Ingelheim | 2011-03-01 |
| Evaluate the Pharmacokinetics, Safety, and Tolerability of Alisporivir in Subjects With Hepatic Impairment Compared to Healthy Subjects (NCT01860326) | Debiopharm International SA | 2011-03-01 |
| Combined PEX, Rituximab and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations (NCT01266317) | Michael Donahoe | 2011-03-01 |
| Er:YAG Ablative Fractional Laser Assisted-Photodynamic Therapy Versus Photodynamic Therapy for Basal Cell Carcinoma (NCT02018679) | Dong-A University | 2011-03-01 |
| Effect of Dose on the Pharmacokinetics of OROS Hydromorphone Under Fasted Conditions in Healthy Taiwanese Participants (NCT01487512) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2011-03-01 |
| Effects of Administration of Fostamatinib on Blood Concentrations of Pioglitazone in Healthy Subjects (NCT01309854) | AstraZeneca | 2011-03-01 |
| Azacitidine With or Without Ceplene/Interleukin-2 in Patients With Higher Risk Myelodysplastic Syndromes (NCT01324960) | Groupe Francophone des Myelodysplasies | 2011-03-01 |
| Effect of Oral Contraceptives After Administration of Semaglutide in Subjects With Type 2 Diabetes (NCT01324505) | Novo Nordisk A/S | 2011-03-01 |
| Single and Multiple Ascending Dose Study of V158866 in Healthy Volunteers (NCT01634529) | Vernalis (R&D) Ltd | 2011-03-01 |
| A Safety Study in Healthy Volunteers of the Single-Use Autoinjector Containing Placebo of BG9418 Interferon Beta-1a With a 25-Gauge × 1-Inch Needle (NCT01313364) | Biogen | 2011-03-01 |
| GLPG0187: Safety, Tolerability and Pharmacokinetics in Patients With Solid Tumors (NCT01313598) | Lakefront Biotherapeutics NV | 2011-03-01 |
| Gene Therapy for Wiskott-Aldrich Syndrome (WAS) (NCT01347242) | Genethon | 2011-03-01 |
| Efficacy of Zingiber Officinalis (Homoeopathic Medicine) in Treatment of Acne Vulgaris (NCT01321632) | Miglani, Anjali | 2011-03-01 |
| Selections of Subjects With Important Changes in Their Cardiac Repolarization Parameters for the Procurement of Skin and Blood Samples (NCT01338441) | Ectycell SASU | 2011-03-01 |
| Mild Versus Conventional Ovarian Stimulation for Poor Responders Undergoing In Vitro Fertilisation (NCT01319708) | National and Kapodistrian University of Athens | 2011-03-01 |
| A Phase I Open Label Dose Escalation Trial of RNA-144101 in the Treatment of Geographic Atrophy (NCT01093170) | Mark Kleinman | 2011-03-01 |
| Safety and Pharmacokinetics Study of ODM-201 in Castrate Resistant Prostate Cancer (NCT01317641) | Orion Corporation, Orion Pharma | 2011-03-01 |
| Tenofovir Gel in Pregnancy and Lactation (NCT01136759) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-03-01 |
| Study of Methyl Aminolaevulinate Photodynamic Therapy With and Without Er:YAG Laser in Bowen's Disease (NCT01912976) | Dong-A University | 2011-03-01 |
| A Study to Evaluate the Safety of MEDI2338 in Subjects With Chronic Obstructive Pulmonary Disease (NCT01322594) | MedImmune LLC | 2011-03-01 |
| Study To Investigate The Potential Drug Drug Interaction (DDI) Between PF-00299804 And Paroxetine In Healthy Subjects (NCT01318031) | Pfizer | 2011-03-01 |
| Effect of Ketoconazole on Regorafenib (BAY73-4506) Pharmacokinetics (NCT01318265) | Bayer | 2011-03-01 |
| Aromatase Inhibitors for Treatment of Uterine Leiomyomas (NCT00945360) | American University of Beirut Medical Center | 2011-03-01 |
| Hepatocyte Transplantation for Liver Based Metabolic Disorders (NCT01345578) | Ira Fox | 2011-03-01 |
| PKC412 and 5-Azacytidine (NCT01202877) | M.D. Anderson Cancer Center | 2011-03-01 |
| Autologous Hematopoietic Stem Cell Transplant in Neuromyelitis Optica (NCT01339455) | University of Calgary | 2011-03-01 |
| Effect of Rifampin on the Pharmacokinetics of BAY73-4506 (NCT01322438) | Bayer | 2011-03-01 |
| VRS-317 in Adult Subjects With Growth Hormone Deficiency (NCT01359488) | Versartis Inc. | 2011-03-01 |
| The Effect of an Adhesive Overlay on the Delivery of Contraceptive Hormones From ORTHO EVRA® in Healthy Women (NCT01535820) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2011-03-01 |
| Efficacy and Safety of Bevacizumab in the Neodjuvant Treatment of Inflammatory Breast Cancer (NCT01880385) | Association Tunisienne de lutte Contre le Cancer | 2011-03-01 |
| Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of QGE031 in Japanese Atopic Male Subjects (NCT01596712) | Novartis Pharmaceuticals | 2011-03-01 |
| Tolerability and Efficacy of Intravenous Infusion of Autologous MSC_Apceth for the Treatment of Critical Limb Ischemia (NCT01351610) | Apceth GmbH & Co. KG | 2011-03-01 |
| A Study of the Safety and Pharmacokinetics of Escalating Doses of DSTP3086S in Patients With Metastatic Castration-Resistant Prostate Cancer (NCT01283373) | Genentech, Inc. | 2011-03-01 |
| Single-Dose And Multiple-Dose Safety And Tolerability Study Of PF-04856883 In Type 2 Diabetic Adult Females (NCT01301456) | Pfizer | 2011-03-01 |
| Pharmacokinetics and Safety Study of Apetrol ES in Healthy Male Volunteers (NCT01342055) | LG Life Sciences | 2011-03-01 |
| Combination of Bortezomib, Fludarabine and Cyclophosphamide Treat Recurrent Mantle Cell Lymphoma (NCT01322776) | Sun Yat-sen University | 2011-03-01 |
| Pioglitazone for Heroin and for Nicotine Dependence (NCT01395797) | New York State Psychiatric Institute | 2011-03-01 |
| A Phase 1 Trial of ABI-011 in Patients With Advanced Solid Tumors or Lymphomas (NCT01163071) | Celgene | 2011-03-01 |
| An Open-label Study in Healthy Male Subjects to Assess the Absorption, Distribution, Metabolism and Excretion of [14C]-Labelled BIA 9-1067 and Metabolites (NCT02169427) | Bial - Portela C S.A. | 2011-03-01 |
| Photodynamic Therapy Using Methyl-5-Aminolevulinate Hydrochloride Cream in Determining Pain Threshold in Patients With Skin Cancer (NCT01292668) | Roswell Park Cancer Institute | 2011-03-01 |
| TAK-329 Glucose Clamp Study (NCT01311076) | Takeda | 2011-03-01 |
| A Study of the Effect of LY2189265 on Two Blood Pressure Drugs (NCT01324388) | Eli Lilly and Company | 2011-03-01 |
| The Effects of Tactile Speech Feedback on Stuttering Frequency (NCT01315730) | University of Mississippi, Oxford | 2011-03-01 |
| A Drug-Drug Interaction Study of Losartan and PA21 (NCT01324752) | Vifor Pharma | 2011-03-01 |
| Safety Study Evaluating Intravenous Infusions of Tigecycline to Treat Acute Myeloid Leukemia (NCT01332786) | University Health Network, Toronto | 2011-03-01 |
| Study to Assess the Safety and Efficacy of THR-18 When Administered to Patients Suffering Acute Ischemic Stroke and Treated With Tissue Plasminogen Activator (tPA) (NCT01253512) | Thrombotech Ltd. | 2011-03-01 |
| Safety, Tolerability and Pharmacokinetics Trial of JDP-205 Injection 10 mg (NCT02024152) | JDP Therapeutics, Inc. | 2011-03-01 |
| LEO 32731 - A Study in Healthy Male Subjects (NCT01310049) | LEO Pharma | 2011-03-01 |
| MK-2206, Paclitaxel and Trastuzumab in Treating Patients With HER2-overexpressing Solid Tumor Malignancies (NCT01235897) | University of California, San Francisco | 2011-03-01 |
| A Study to Compare Two Forms of LY2608204 in Healthy People (NCT01313286) | Eli Lilly and Company | 2011-03-01 |
| A Study of Intravenous XMT-1001 in Patients With Advanced Solid Tumors (NCT00455052) | Mersana Therapeutics | 2011-03-01 |
| A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer (NCT01337518) | Enzon Pharmaceuticals, Inc. | 2011-03-01 |
| Autologous Mesenchymal Stem Cell (MSC) Transplantation in MS (NCT00813969) | The Cleveland Clinic | 2011-03-01 |
| Study to Evaluate the Bronchoprotective Effects of a Single Dose of N6022 in Patients With Mild Asthma (NCT01316315) | Nivalis Therapeutics, Inc. | 2011-03-01 |
| Study to Evaluate the Safety of the Vaccine Prepared sm14 Against Schistosomiasis (NCT01154049) | Oswaldo Cruz Foundation | 2011-03-01 |
| A Clinical Trial for Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children and Infants (NCT01313715) | Jiangsu Province Centers for Disease Control and Prevention | 2011-03-01 |
| Contribution of Angiotensin II to Supine Hypertension in Autonomic Failure (NCT01292694) | Vanderbilt University | 2011-03-01 |
| Repeated Dosing Study With a New Insulin Glargine Formulation and Lantus® in Patients With Type 1 Diabetes Mellitus (NCT01349855) | Sanofi | 2011-03-01 |
| Human Repeat Insult Patch Test of Wound Dressings (NCT01368146) | Covalon Technologies Inc. | 2011-03-01 |
| Pharmacokinetic and Pharmacodynamic Properties of BIOD-105 and BIOD-107 Compared to Humalog® in Subjects With Type 1 Diabetes (NCT01334151) | Biodel | 2011-03-01 |
| Study of Continuous Dosing of Sunitinib in Non GIST Sarcomas With Concomitant Radiotherapy (NCT01308034) | Centre Leon Berard | 2011-03-01 |
| Curcumin Pharmacokinetics (NCT01330810) | University of North Carolina, Chapel Hill | 2011-03-01 |
| Iloprost Effects on Gas Exchange and Pulmonary Mechanics (NCT01274481) | University of Oklahoma | 2011-03-01 |
| Autologous Chondrocyte Intra-articular Implantation in Patients With Severe Hip Osteoarthritis (NCT01500811) | Royan Institute | 2011-03-01 |
| Phase 1/2 Lyme Vaccine Study (NCT01504347) | Baxalta now part of Shire | 2011-03-01 |
| Gemcitabine, Cisplatin, Plus Lenalidomide as First-line Therapy for Patients With Metastatic Urothelial Carcinoma (NCT01342172) | Icahn School of Medicine at Mount Sinai | 2011-03-01 |
| Endoxifen in Adults With Hormone Receptor Positive Solid Tumors (NCT01273168) | National Cancer Institute (NCI) | 2011-03-01 |
| Safety and Pharmacokinetic Study of MM-302 in Patients With Advanced Breast Cancer (NCT01304797) | Merrimack Pharmaceuticals | 2011-03-01 |
| A Study of ARRY-382 in Patients With Selected Advanced or Metastatic Cancers (NCT01316822) | Array Biopharma, now a wholly owned subsidiary of Pfizer | 2011-03-01 |
| Safety, Tolerability, and Pharmacokinetics (PK) of CTP-499 (NCT01328821) | Concert Pharmaceuticals | 2011-03-01 |
| A Study of the Pharmacokinetics And Pharmacodynamics of Intravenously Administered Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis C And Previous Non-Response to Pegylated Interferon And Ribavirin Combination Therapy (NCT01337375) | Hoffmann-La Roche | 2011-03-01 |
| BE Study of the Fixed Dose Combination of 5 mg Saxagliptin and 500 mg Metformin HCl XR Tablet Relative to a 5 mg Saxagliptin (Onglyza™) Tablet and a 500 mg Metformin HCl XR (Glifage® XR Marketed in Brazil by Merck S.A.) Tablet Co-Administered to Healthy Subjects in the Fasted and Fed States (NCT01305551) | AstraZeneca | 2011-03-01 |
| Healthy Volunteers, Absorption, Distribution, Metabolism and Excretion (ADME) Study With Single Oral Administration of [14C] AZD8931 (NCT01284595) | AstraZeneca | 2011-03-01 |
| TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer (NCT01294293) | Gynecologic Oncology Group | 2011-03-01 |
| High-Dose 131I-MIBG Therapy Combined With Vincristine and Five Days of Irinotecan for Resistant/Relapsed Neuroblastoma (NCT01313936) | University of California, San Francisco | 2011-03-01 |
| Clinical Study to Assess Change in Upper Airway Geometry Between Upright and Supine Position (NCT01594164) | FLUIDDA nv | 2011-03-01 |
| Study of Radiotherapy Administered in Combination With Ipilimumab in Patients With Unresectable Stage III or Stage IV Advanced Malignant Melanoma (NCT01557114) | Gustave Roussy, Cancer Campus, Grand Paris | 2011-03-01 |